Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age. (Q40275080)
Jump to navigation
Jump to search
scientific article published on 7 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age. |
scientific article published on 7 September 2012 |
Statements
1 reference
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age. (English)
1 reference
Gustavo H Dayan
1 reference
Joan Bevilacqua
1 reference
Dorothy Coleman
1 reference
Aileen Buldo
1 reference
George Risi
1 reference
7 September 2012
1 reference
6656-6664
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference